A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/505 (2006.01) A61K 31/166 (2006.01) A61K 31/198 (2006.01) A61K 31/216 (2006.01) A61K 31/506 (2006.01) A61K 31/675 (2006.01) A61K 31/7068 (2006.01) A61K 38/21 (2006.01) A61K 47/48 (2006.01) A61P 29/00 (2006.01) A61P 37/06 (2006.01) A61K 49/06 (2006.01) G01N 33/564 (2006.01) G01N 33/569 (2006.01)
Patent
CA 2641160
Alpha 4 inhibitors are used in treatment of inflammatory and autoimmune diseases, such as multiple sclerosis, Crohn's Disease, rheumatoid arthritis and asthma. Rare occurrences of progressive multifocal leucoencephalopathy during treatment with an alpha-4 agent suggest the possibility that it may be related to such treatment. Monitoring for the JC virus and educating caregivers and patients about the manifestations of progressive multifocal leucoencephalopathy can improve the safety of alpha 4 inhibitor therapy.
Les inhibiteurs alpha-4 selon l'invention sont utilisés dans le traitement de maladies inflammatoires et auto-immunes, telles que la sclérose en plaques, la maladie de Crohn, la polyarthrite rhumatoïde et l'asthme. De rares cas de leucoencéphalopathie multifocale progressive durant le traitement avec un agent alpha-4 suggèrent un lien avec ce traitement. La surveillance du virus JC et l'information du personnel soignant et des patients concernant les manifestations de leucoencéphalopathie multifocale progressive peuvent améliorer l'innocuité de la thérapie à base d'inhibiteur alpha-4.
Lieberburg Ivan
Elan Pharmaceuticals Inc.
Kirby Eades Gale Baker
LandOfFree
Methods of treating inflammatory and autoimmune diseases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating inflammatory and autoimmune diseases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating inflammatory and autoimmune diseases... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2089895